Particularly in breast cancer, chromosome amplification and mRNA up-regulation of CHD4 were observed, and higher expression of CHD4 is associated with poorer patient outcomes in triple negative (or basal) breast cancer cells (30,31). This evidence concerns the gene CHD4 and breast carcinoma.